No Data
No Data
Madrigal Pharmaceuticals (MDGL): Among Billionaire John Paulson's Stocks With Huge Upside Potential
New Analyst Forecast: $MDGL Given $420.0 Price Target
BofA Securities Maintains Madrigal Pharmaceuticals(MDGL.US) With Sell Rating, Maintains Target Price $248
Madrigal Pharmaceuticals Price Target Raised to $460.00/Share From $422.00 by B. Riley Securities
Madrigal Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Madrigal Pharmaceuticals Analyst Ratings